11630 SW 97 Street, Miami, Florida 33176, US

Advertising Driven Press Release Distribution

Tag: NeuExcell

NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington’s Disease

Press Release
Using NeuExcell’s neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington’s Disease. Spark Therapeutic’s excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform may advance the development of the program and overcome hurdles and challenges of viral vectors for gene therapy. NeuExcell is eligible to receive upfront, license fees, R&D and Sales milestone payments up to approximately. Read More>>

NeuExcell Therapeutics names Russ Addis as Vice President, Research

Press Release
August 23, 2021. State College, Pennsylvania  – NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Russ Addis, Ph.D. to the new position of Vice President, Research, effective immediately. Dr. Addis will report directly to Dr. Ronald HW Lorijn, Chief Executive Officer, and will oversee the Company’s gene therapy programs. Dr. Addis leads a growing organization and will build on the earlier activities and current expansion of the lab and. Read More>>

Subscribe to Our Newsletter

For exclusive content regarding the latest trends in the world of Press Release distribution.